Sandoz Specialty Summit 2024: Advancing patient access to quality treatments in Vietnam
Sandoz Vietnam, the wholly owned subsidiary of the global leader in generic and biosimilar medicines, today announced its inaugural Specialty…
Sandoz Vietnam, the wholly owned subsidiary of the global leader in generic and biosimilar medicines, today announced its inaugural Specialty…
World-leader in biosimilar and generic pharmaceuticals secures Vietnam business license Sandoz, the global leader in generic and biosimilar medicines, has…
Medix Global (‘Medix’) sees significant opportunity to invest in Vietnam’s burgeoning digital healthcare industry. The global healthcare services provider is…
Sandoz Vietnam, the wholly owned subsidiary of the global leader in generic and biosimilar medicines, today announced its inaugural Specialty…
World-leader in biosimilar and generic pharmaceuticals secures Vietnam business license Sandoz, the global leader in generic and biosimilar medicines, has…
Medix Global (‘Medix’) sees significant opportunity to invest in Vietnam’s burgeoning digital healthcare industry. The global healthcare services provider is…